World's first malaria vaccine moves closer to use in Africa

The world`s first malaria vaccine, made by GlaxoSmithKline, could be approved by international regulators for use in Africa from October after final trial data showed it offered partial protection for up to four years.

Human trial of Ebola vaccines to begin soon: WHO

Two leading Ebola vaccines appear safe on humans and trials on volunteers will begin soon to combat the deadly epidemic in West Africa, the WHO announced here Friday.

Ebola vaccine promising in first human trials: National Institutes of Health
Ebola vaccine promising in first human trials: National Institutes of Health

An experimental Ebola vaccine made by GlaxoSmithKline caused no serious side effects and produced an immune response in all 20 healthy volunteers who received it in an early-stage clinical trial, scientists reported on Wednesday in the New England Journal of Medicine.

GSK hepatitis C shot shows promise, bodes well for Ebola vaccines

A new hepatitis C vaccine from GlaxoSmithKline based on the same technology as an experimental Ebola shot being fast-tracked through human trials has shown promise in early clinical tests, prompting strong and broad immune responses.

Drugmakers to join forces to make millions of Ebola vaccine doses

Leading drugmakers plan to work together to speed up the development of an Ebola vaccine and hope to produce millions of doses for use next year.

Oxford experts test vaccine against Ebola

Experts at England's University of Oxford Wednesday launched clinical trials of a vaccine against the Ebola virus, which has killed more than half of the over 4,700 people affected in West Africa.

Ebola vaccine trial finds 'no red flags': US Senate testimony

A key safety trial of an experimental Ebola vaccine manufactured by GlaxoSmithKline has injected 10 healthy volunteers since Sept. 2, and so far "no red flags" indicating serious adverse reactions have been found.

Experimental vaccine provides 'long-term' immunity against Ebola in monkeys

 A new study has revealed that experimental vaccines have shown to provide "long-term" immunity against Ebola virus in monkeys , the raising a prospect of successful human trials.

Ebola vaccine trials being fast-tracked: Researchers

Safety trials on an Ebola vaccine are being fast-tracked, meaning it could be given to healthy volunteers as early as September, researchers said today.

Ebola vaccine to trial next month, may be ready by 2015: UN

Clinical trials of a preventative vaccine for the Ebola virus made by British pharma company GlaxoSmithKline may begin next month and made available by 2015, the World Health Organisation said on Saturday.

Ebola vaccine to trial next month, may be ready by 2015: UN

Clinical trials of a preventative vaccine for the Ebola virus made by British pharma company GlaxoSmithKline may begin next month and made available by 2015, the World Health Organisation said today.

Foreigners indicted in China for acting as private detectives

A foreign couple, stated to be private detectives hired by British drug maker GlaxoSmithKline (GSK), was indicted by Chinese prosecutors in Shanghai for illegally obtaining private information of Chinese citizens.

Poland extends corruption probe into Britain`s GSK

Polish prosecutors said Monday they have extended a probe into allegations that British pharmaceutical giant GlaxoSmithKline bribed doctors into promoting one of its drugs.

Scientists start to unpick narcolepsy link to GSK flu vaccine

Scientists have found that the sleep disorder narcolepsy can sometimes be triggered by a scientific phenomenon known as "molecular mimicry", offering a possible explanation for its link to a GlaxoSmithKline H1N1 pandemic flu vaccine.

Flu vaccine helps ward off serious child illness

The flu vaccine prevents the virus more than half the time in children and can also ward off more serious sickness, said the findings of a major clinical trial Wednesday.

GlaxoSmithKline heart drug misses goal in major study

An experimental GlaxoSmithKline drug, designed to fight heart disease in a new way, failed to meet its main goal in a major late-stage clinical study, dealing a blow to one of the company`s biggest new treatment hopes.

Indian researcher `comes up with strategy to stop superbugs`

An Indian origin scientist is among the winners of a GlaxoSmithKline (GSK) "academic drug hunter" competition that will help fast track his lab`s work in combating drug-resistant bacteria.

New `wonder` malaria vaccine may be too pricey for success

A researcher has said that a promising new malaria vaccine being tested by GlaxoSmithKline is a step in the right direction, but much more economical methods are needed.

Jubilant receives USFDA approval for two generic drugs

Drug firm Jubilant Life Sciences Ltd Friday said it has received approval from the US Food and Drugs Administration (USFDA) to market generic versions of GlaxoSmithKline`s anti-depressant Wellbutrin SR and smoking cessation aid, Zyban.

GSK aims to market world`s first malaria vaccine by 2015

British drugmaker GlaxoSmithKline will seek marketing approval for the world`s first malaria vaccine next year after trial data showed the shot significantly cut cases of the disease in African children.